The Genomics Revolution and RadiotherapyCitation formats

Standard

The Genomics Revolution and Radiotherapy. / West, C. M L; Elliott, R. M.; Burnet, N. G.

In: Clinical Oncology, Vol. 19, No. 6, 08.2007, p. 470-480.

Research output: Contribution to journalArticle

Harvard

West, CML, Elliott, RM & Burnet, NG 2007, 'The Genomics Revolution and Radiotherapy', Clinical Oncology, vol. 19, no. 6, pp. 470-480. https://doi.org/10.1016/j.clon.2007.02.016

APA

West, C. M. L., Elliott, R. M., & Burnet, N. G. (2007). The Genomics Revolution and Radiotherapy. Clinical Oncology, 19(6), 470-480. https://doi.org/10.1016/j.clon.2007.02.016

Vancouver

West CML, Elliott RM, Burnet NG. The Genomics Revolution and Radiotherapy. Clinical Oncology. 2007 Aug;19(6):470-480. https://doi.org/10.1016/j.clon.2007.02.016

Author

West, C. M L ; Elliott, R. M. ; Burnet, N. G. / The Genomics Revolution and Radiotherapy. In: Clinical Oncology. 2007 ; Vol. 19, No. 6. pp. 470-480.

Bibtex

@article{f654144d609f4ade971b8e8f8ed83ed5,
title = "The Genomics Revolution and Radiotherapy",
abstract = "The expansion of our knowledge through the Human Genome Project has been accompanied by the development of new high-throughput techniques, which provide extensive capabilities for the analysis of a large number of genes or the whole genome. These assays can be carried out in various clinical samples at the DNA (genome), RNA (transcriptome) or protein (proteome) level. There is a belief that this genomic revolution, i.e. sequencing of the human genome and developments in high-throughput technology, heralds a future of personalised medicine. For clinical oncology, this progress should increase the possibility of predicting individual patient responses to radiotherapy. This review highlights some of the work involving sparsely ionising radiation and the new technologies. {\circledC} 2007 The Royal College of Radiologists.",
keywords = "Genomics, predictive assays, radiobiology",
author = "West, {C. M L} and Elliott, {R. M.} and Burnet, {N. G.}",
year = "2007",
month = "8",
doi = "10.1016/j.clon.2007.02.016",
language = "English",
volume = "19",
pages = "470--480",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Co. Ltd",
number = "6",

}

RIS

TY - JOUR

T1 - The Genomics Revolution and Radiotherapy

AU - West, C. M L

AU - Elliott, R. M.

AU - Burnet, N. G.

PY - 2007/8

Y1 - 2007/8

N2 - The expansion of our knowledge through the Human Genome Project has been accompanied by the development of new high-throughput techniques, which provide extensive capabilities for the analysis of a large number of genes or the whole genome. These assays can be carried out in various clinical samples at the DNA (genome), RNA (transcriptome) or protein (proteome) level. There is a belief that this genomic revolution, i.e. sequencing of the human genome and developments in high-throughput technology, heralds a future of personalised medicine. For clinical oncology, this progress should increase the possibility of predicting individual patient responses to radiotherapy. This review highlights some of the work involving sparsely ionising radiation and the new technologies. © 2007 The Royal College of Radiologists.

AB - The expansion of our knowledge through the Human Genome Project has been accompanied by the development of new high-throughput techniques, which provide extensive capabilities for the analysis of a large number of genes or the whole genome. These assays can be carried out in various clinical samples at the DNA (genome), RNA (transcriptome) or protein (proteome) level. There is a belief that this genomic revolution, i.e. sequencing of the human genome and developments in high-throughput technology, heralds a future of personalised medicine. For clinical oncology, this progress should increase the possibility of predicting individual patient responses to radiotherapy. This review highlights some of the work involving sparsely ionising radiation and the new technologies. © 2007 The Royal College of Radiologists.

KW - Genomics

KW - predictive assays

KW - radiobiology

U2 - 10.1016/j.clon.2007.02.016

DO - 10.1016/j.clon.2007.02.016

M3 - Article

VL - 19

SP - 470

EP - 480

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 6

ER -